Huntington National Bank Night Hawk Biosciences, Inc. Transaction History
Huntington National Bank
- $12.3 Billion
- Q1 2024
A detailed history of Huntington National Bank transactions in Night Hawk Biosciences, Inc. stock. As of the latest transaction made, Huntington National Bank holds 220 shares of NHWK stock, worth $35. This represents 0.0% of its overall portfolio holdings.
Number of Shares
220Holding current value
$35% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NHWK
# of Institutions
32Shares Held
2.21MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY397KShares$63,4710.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny391KShares$62,6180.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA364KShares$58,1950.0% of portfolio
-
Warberg Asset Management LLC Winnetka, IL283KShares$45,2860.32% of portfolio
-
Geode Capital Management, LLC Boston, MA211KShares$33,8370.0% of portfolio
About NightHawk Biosciences, Inc.
- Ticker NHWK
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,661,500
- Market Cap $4.11M
- Description
- NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...